First Human Trials of AI-Designed Vaccine
Researchers at University of Cambridge have tested first vaccine created entirely by artificial intelligence on humans. This vaccine targets several viruses,including those causing major outbreaks like Sars,Mers,and Covid-19.
Results from small,early-stage trial showed some immune response among participants. Impact was limited,researchers still see potential for AI to shake up vaccine development. Jonathan Heeney,Cambridge researcher and study co-author, emphasized change,saying, “We’ve turned vaccine development from being reactive to being proactive.”
“Universal vaccine” idea could mean stronger defenses against future pandemics. Current vaccines,like for influenza and Covid-19, often need updates to tackle changing strains . Aim is this vaccine might cut need for constant adjustments,offering more stable viral protection.
World still battling infectious diseases,this trial is a step toward smarter public health solutions . Researchers keep exploring what their findings mean,looking to a future where vaccines get produced faster and more efficiently...
